AstraZeneca completes agreement with LEO Pharma This

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AstraZeneca completes agreement with LEO Pharma

This announcement contains inside information 16 August 2016 07:00 ASTRAZENECA COMPLETES GLOBAL LICENCING AGREEMENT WITH LEO PHARMA FOR TRALOKINUMAB AstraZeneca today announced that it has completed the licensing agreement (https://www.astrazeneca.com/media-centre/press -releases/2016/astrazeneca-enters-licensing-agreements-with-leo-pharma-in-skin -diseases-01072016.html) with LEO Pharma A/S (LEO Pharma), a specialist in dermatology care, for the global licence to tralokinumab in skin diseases. Tralokinumab is an IL-13 monoclonal antibody that has completed a Phase IIb trial for the treatment of patients with atopic dermatitis, an inflammatory skin disease resulting in itchy, red, swollen and cracked skin. Upon completion of the agreement, LEO Pharma made a payment to AstraZeneca of $115 million for the exclusive, global rights to tralokinumab in atopic dermatitis and any future additional dermatology indications. As AstraZeneca will retain a significant ongoing interest in tralokinumab, the upfront payment, along with all future commercial milestone and royalty payments, will be reported as Externalisation Revenue in the Company's financial statements. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com CONTACTS Media Enquiries Neil UK/Global    +44 203 749 5637 Burrows Vanessa UK/Global    +44 203 749 5736 Rhodes Karen UK/Global    +44 203 749 5634 Birmingham Rob UK/Global    +44 203 749 5821 Skelding Jacob Lund    Sweden    +46 8 553 260 20 Michele US    +1 302 885 2677 Meixell Investor Relations UK Thomas Kudsk +44 203 749 5712 Larsen Craig Marks  Finance, Fixed Income, M&A +44 7881 615 764 Nick Stone  Respiratory & Autoimmunity +44 203 749 5716 Henry Oncology  +44 203 749 5797 Wheeler Christer Infection & Neuroscience +44 203 749 5711 Gruvris US Lindsey Cardiovascular & Metabolic   Diseases +1 240 543 7970 Trickett Mitchell  Oncology +1 240 477 3771 Chan Toll free +1 866 381 7277 Adrian Kemp Company Secretary AstraZeneca PLC -ENDS-

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 154

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
CassTime's AI Solution Eases Global Parts Market Strains

Updated Category News Views 150

Driving Innovation in the Auto Aftermarket When car parts become a global jigsaw puzzle, you need more than wrenches to solve it. Enter CassTime with its AI-driven 'T+D Solution'—a tangible answer to the woes of data matching and repair capability bottlenecks plaguing the automotive aftermarket worldwide. Taming the Global Parts Beast Pull back the curtain on AAPEX 2026...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 84

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 184

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 211

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 83

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 167

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 156

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Texas Community Bancshares Acquires SJCB for $9.5M

Updated Category News Views 78

Texas Community Bancshares Makes a Bold Move In the gritty world of finance, where deals and dollars often rule over sentimentality, Texas Community Bancshares, Inc. (NASDAQ: TCBS) has decided it's game time by acquiring The Banc of San Jacinto County Bancshares, Inc. in a decisive all-cash transaction. Yep, they’re throwing $9.5 million cash on the table to grab a...

Continue Reading
ICW Group Insurance Companies Unveils New Specialty Division

Updated Category News Views 421

ICW Group Insurance Companies Introduces ICW Specialty ICW Group Insurance Companies proudly announces the creation of ICW Specialty, a newly minted business unit that will be launched through VerTerra Insurance, the company's provider of Excess and Surplus lines. This significant step indicates ICW Group's ongoing commitment to innovation in the insurance space,...

Continue Reading
Discover the Cutting-Edge OMTech Solis Duo Laser Engraver

Updated Category News Views 285

Introducing the Revolutionary OMTech Solis Duo Laser Engraver OMTech has launched the exciting new Solis Duo, an advanced dual-laser engraver that combines the power of fiber and diode technologies. This innovative machine is designed for creators seeking efficient and high-quality results without the hassle of managing multiple setups. As a compact unit, it delivers a...

Continue Reading
Navigating Labor Tensions: Payscale's Insights for 2025

Updated Category News Views 276

Understanding the Labor Landscape for 2025 As organizations brace for the potential challenges in labor relations, Payscale's recent report sheds light on the evolving landscape regarding compensation and employee expectations. This report highlights the pivotal shifts expected in the realm of human resources, particularly in relation to pay transparency and equity. The...

Continue Reading
Elon Musk's X Experiences Significant Outage Amid Cyberattack Claims

Updated Category News Views 212

Elon Musk's X Faces Major Service Disruption Recently, Elon Musk's platform X, which was formerly known as Twitter, faced a significant service disruption that affected users across various regions. Reports indicated that more than 41,000 users encountered issues while trying to access the app and website. The majority of complaints, accounting for 58%, were directly...

Continue Reading